Lv31
270 积分 2023-07-20 加入
Prostate-Specific Membrane Antigen PET for Patients With Postoperative Recurrence of Prostate Cancer
5小时前
求助中
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
4天前
已完结
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
6天前
已完结
The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers
6天前
已完结
Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)
8天前
已完结
68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer
8天前
已完结
Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and Multiparametric MRI for Pelvic Lymph Node Staging Prior to Radical Prostatectomy in Patients With Intermediate to High-Risk Prostate Cancer: A Meta-Analysis
8天前
已完结
Results of the Prospective Randomized UroFollow Trial Comparing Marker-guided Versus Cystoscopy-based Surveillance in Patients with Low/Intermediate-risk Bladder Cancer
15天前
已完结
Targeted alpha therapy: a comprehensive analysis of the biological effects from "local-regional-systemic" dimensions
1个月前
已完结
Promise without practice — charting the path forward for bladder cancer biomarkers
2个月前
已完结
皖公网安备34019202002308
